Fortress Biotech to Participate in Four March 2021 Virtual Investor Conferences
NEW YORK, March 04, 2021 (GLOBE NEWSWIRE) — Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”), an…
NEW YORK, March 04, 2021 (GLOBE NEWSWIRE) — Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”), an…
SAN DIEGO, March 04, 2021 (GLOBE NEWSWIRE) — Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage…
Proceeds will fund advancement of the company’s pipeline of protease-activated T cell engagers and cytokines…
CAMBRIDGE, United Kingdom and CAMBRIDGE, Mass., March 04, 2021 (GLOBE NEWSWIRE) — F-star Therapeutics, Inc….
CAMBRIDGE, Mass., March 04, 2021 (GLOBE NEWSWIRE) — eGenesis, a gene-editing and genome-engineering company developing…
BOSTON, March 04, 2021 (GLOBE NEWSWIRE) — Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company…
Philips Incisive CT in use with patient Philips Incisive CT in use by tech operator…
MENLO PARK, Calif. and GREENWICH, Conn. and BOSTON, March 04, 2021 (GLOBE NEWSWIRE) — Longitude…
NORCROSS, Ga., March 04, 2021 (GLOBE NEWSWIRE) — Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer…
Loughborough, England, March 04, 2021 (GLOBE NEWSWIRE) — Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or…